Novo submits high-dose Wegovy for FDA approval using vouchernews2025-11-26T17:45:45+00:00November 26th, 2025|Endpoints News|
Delayed panel on vaccine injury payments to meet next monthnews2025-11-26T16:44:30+00:00November 26th, 2025|Endpoints News|
FDA pushes back Ascendis’ dwarfism drug decision date by three monthsnews2025-11-26T13:57:06+00:00November 26th, 2025|Endpoints News|
Otsuka’s anti-APRIL antibody gets FDA approval for kidney disease IgANnews2025-11-26T00:52:17+00:00November 26th, 2025|Endpoints News|
FDA approves Novartis’ Itvisma for older patients with spinal muscular atrophynews2025-11-25T12:09:26+00:00November 25th, 2025|Endpoints News|
FDA’s Pazdur is said to raise questions about commissioners actions, new vouchernews2025-11-24T21:04:48+00:00November 24th, 2025|Endpoints News|
Top Makary aide Jain-Nagpal remains at the FDA after White House pushbacknews2025-11-21T20:25:04+00:00November 21st, 2025|Endpoints News|
FDA investigates child death potentially related to Takeda’s enzyme replacement therapynews2025-11-21T16:11:24+00:00November 21st, 2025|Endpoints News|
FDA will allow email ‘clarifications’ after pharma company meetingsnews2025-11-20T14:34:56+00:00November 20th, 2025|Endpoints News|
FDA approves Bayer’s HER2-mutated lung cancer drugnews2025-11-19T20:28:57+00:00November 19th, 2025|Endpoints News|
